Share on LinkedInShare on LinkedIn

ARTICLE · 15 MAY 2025

Antitrust & Competition Healthcare Quarterly Update Q1 2025

While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy developments in the antitrust space...

United StatesAntitrust/Competition Law

I. Summary

While M&A activity has slowed in the tail end of the first quarter of 2025, including in healthcare, there have been several noteworthy developments in the antitrust space in the first 100 days of the Trump Administration. The Federal Trade Commission (FTC), under new Chairman Andrew Ferguson, has already launched its first merger challenge, affirmed its acceptance of the 2023 Merger Guidelines, reinstituted early termination of HSR filings, and allowed the new HSR filing rules to take effect. Further, President Trump fired the two sitting Democratic Commissioners in March 2025, leaving the leadership of the FTC in the hands of the three sitting Republican Commissioners. Meanwhile, in addition to joining the FTC in affirming the Merger Guidelines and HSR filing rules, the Department of Justice Antitrust Division (DOJ) under Assistant Attorney General Gail Slater announced an "Anticompetitive Regulations Task Force," which will seek to

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from